Veeva Systems Lifts Outlook on CRM Wins

Veeva Systems(NYSE:VEEV) reported fiscal second quarter 2026 results on August 27, 2025, delivering $789 million in revenue and raising full-year billings guidance by $35 million. The quarter featured a strategic resolution with(NYSE: IQV), rapid Vault CRM adoption among top-20 pharmaceutical customers, and accelerated progress on industry-specific AI agents. The following insights highlight the most significant developments and their long-term implications for investors.

Veeva previously faced restrictions on integrating IQVIA’s industry-leading data into its commercial products, such as Veeva Network and Nitro, which limited competitiveness. The company has now migrated 100 customers to Vault CRM after moving offSalesforce(NYSE: CRM) OEM constraints, and both Veeva and IQVIA are considered foundational platforms by pharmaceutical customers.

-- Peter Gassner, Chief Executive Officer

Continue reading

Source Fool.com